What immediate actions are recommended for a patient who has taken methotrexate 15 mg daily for four consecutive days?

Immediate Management of Methotrexate Overdose

This patient has experienced a potentially life-threatening methotrexate overdose requiring immediate hospitalization, leucovorin rescue therapy, aggressive hydration with urinary alkalinization, and intensive monitoring for bone marrow suppression and organ toxicity. 1

Critical Understanding of the Error

Methotrexate is prescribed as a weekly dose, not daily. Taking 15 mg daily for 4 consecutive days means the patient received 60 mg total instead of the intended 15 mg weekly dose—a 4-fold overdose that constitutes acute methotrexate toxicity. 2, 3

Immediate Actions Required

1. Emergency Hospitalization

• Admit immediately to a facility capable of intensive monitoring and supportive care 3, 4
• This is a medical emergency with potential for fatal outcomes including septic shock, as documented in similar cases 3

2. Leucovorin (Folinic Acid) Rescue - START IMMEDIATELY

• Leucovorin is the preferred antidote for methotrexate poisoning 4
• Standard dosing: 15 mg orally, IV, or IM every 6 hours 1
• Continue until methotrexate levels fall below toxic range 1
• Do NOT delay leucovorin while awaiting laboratory results 4
• Higher doses may be required based on serum methotrexate levels (see monitoring section) 1

3. Aggressive Hydration and Urinary Alkalinization

• Administer IV fluids at 3 liters/m²/day (approximately 125 mL/m²/hr) 1
• Add sodium bicarbonate to maintain urine pH >7.0 to prevent methotrexate precipitation in renal tubules 1
• Continue hydration for at least 2 days after methotrexate levels become safe 1

4. Immediate Laboratory Assessment

Baseline labs (STAT):

• Complete blood count with differential (assess for bone marrow suppression) 2, 1
• Comprehensive metabolic panel including:
  • Serum creatinine and calculate creatinine clearance 1
  • Liver function tests (AST, ALT, bilirubin, alkaline phosphatase, albumin) 2, 5
  • Electrolytes 1
• Serum methotrexate level (critical for guiding leucovorin dosing) 1, 6

Serial monitoring:

• Repeat serum methotrexate and creatinine at 24 hours, then at least daily until methotrexate level falls below 0.05 micromolar (5 x 10⁻⁸ mol/L) 1
• Daily CBC to monitor for myelosuppression 2, 4
• Daily renal function and electrolytes 1

Leucovorin Dose Adjustment Based on Methotrexate Levels

The FDA label provides specific guidance for adjusting leucovorin based on serum methotrexate concentrations and timing 1:

• If methotrexate elimination is delayed (levels remain elevated at 24,42, or 48 hours), increase leucovorin dose proportionally to the methotrexate concentration 1, 6
• Standard 15 mg every 6 hours may be insufficient if methotrexate levels are significantly elevated 6
• Continue leucovorin until methotrexate level is <0.05 micromolar 1

Glucarpidase Consideration

Glucarpidase may be indicated if: 4, 7

• Serum creatinine is significantly elevated (indicating methotrexate-induced acute kidney injury) AND
• Methotrexate levels remain dangerously high at specific timepoints 7
• Most effective when given within 48-60 hours of methotrexate exposure 7
• Consult toxicology or oncology immediately if renal function deteriorates 7

Monitor for Life-Threatening Toxicities

Clinical surveillance for signs of methotrexate toxicity (as warned in guidelines) 2:

• Bone marrow suppression: fever, infection, unexplained bruising/bleeding, severe fatigue 2, 4
• Mucositis: mouth ulcers, severe oral pain 2, 3
• Gastrointestinal toxicity: nausea, vomiting, abdominal pain, diarrhea 2, 3
• Hepatotoxicity: dark urine, jaundice 2
• Pulmonary toxicity: new cough, dyspnea 2, 4
• Renal failure: oliguria, rising creatinine 1, 4
• Dermatologic toxicity: extensive bullous or pustular lesions (as seen in fatal cases) 3

Critical Pitfalls to Avoid

• Never give leucovorin intrathecally 1
• Do not delay leucovorin rescue while awaiting methotrexate levels—start empirically 4
• Do not underestimate the severity: this dosing error has resulted in documented fatalities from septic shock and multi-organ failure 3
• Patients with delayed methotrexate elimination are at risk for irreversible oliguric renal failure requiring dialysis 1
• High-flux hemodialysis may be necessary if renal failure develops despite leucovorin and hydration 1

Multidisciplinary Consultation

• Immediate consultation with toxicology or clinical pharmacology 4
• Consider oncology consultation for complex cases or if glucarpidase is needed 7
• Nephrology consultation if acute kidney injury develops 1, 4

Prevention of Future Errors

This represents a medication administration error with shared responsibility among prescriber, pharmacist, and nursing staff 3. The British Association of Dermatologists emphasizes that patients must be explicitly counseled on weekly dosing schedules and tablet strength before prescribing 2.